[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Illumina Inc (ILMN)

Illumina Inc (ILMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
5 Revealing Analyst Questions From Illumina’s Q1 Earnings Call

5 Revealing Analyst Questions From Illumina’s Q1 Earnings Call

ILMN : 141.88 (+2.29%)
3 Profitable Stocks We’re Skeptical Of

3 Profitable Stocks We’re Skeptical Of

ILMN : 141.88 (+2.29%)
TSN : 68.38 (+0.65%)
CNXN : 66.65 (+1.99%)
ILMN Q1 Deep Dive: Clinical Sequencing Fuels Growth as NovaSeq X Demand Surges

ILMN Q1 Deep Dive: Clinical Sequencing Fuels Growth as NovaSeq X Demand Surges

ILMN : 141.88 (+2.29%)
Illumina (NASDAQ:ILMN) Posts Better-Than-Expected Sales In Q1 CY2026

Illumina (NASDAQ:ILMN) Posts Better-Than-Expected Sales In Q1 CY2026

ILMN : 141.88 (+2.29%)
Illumina: Q1 Earnings Snapshot

Illumina: Q1 Earnings Snapshot

ILMN : 141.88 (+2.29%)
Illumina Reports Financial Results for First Quarter of Fiscal Year 2026

SAN DIEGO , April 30, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the first quarter of fiscal year 2026.

ILMN : 141.88 (+2.29%)
Illumina's Multiomics Narrative Meets a Market That Already Priced in the Recovery

Barchart Research What to Expect from ILMN Earnings ILMN Generated April 29, 2026 Current Price $120.37 EPS Estimate $$1.05 Consensus Rating Moderate Buy Average Move 8.41% Illumina's Multiomics Narrative...

ILMN : 141.88 (+2.29%)
Illumina (ILMN) Q1 Earnings Report Preview: What To Look For

Illumina (ILMN) Q1 Earnings Report Preview: What To Look For

ILMN : 141.88 (+2.29%)
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows

Illumina launches DRAGEN v4.5, unlocking deep biological signals in complex regions and challenging sample types for rare disease, oncology research

ILMN : 141.88 (+2.29%)
Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease

Dataset will drive crucial insights to accelerate scientific discovery and ultimately improve pediatric patient care.

ILMN : 141.88 (+2.29%)

Barchart Exclusives

How to Buy RKLB for a 20% Discount, or Achieve a 60% Annual Return
On Friday, with Rocket Lab Corporation (RKLB) trading at $105.47, the June put option with a strike price of $90 was trading around $5.55. Traders selling this put would receive $555 in option premium. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.